Velcade and blood creatinine increased Patient Reports February 11, 2012

Velcade Side Effects Report #5823954-5
Velcade side effect was reported by a Physician from UNITED STATES on July 11, 2008. Male patient, 69 years of age, weighting 144.0 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, herpes zoster, tumour lysis syndrome. Velcade dosage: 1.6MG/M2. During the same period patient was treated with RITUXAN, OLMESARTAN MEDOXOMIL, FOSAMAX. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5424517-6
Velcade side effect was reported by a Physician from FRANCE on Aug 13, 2007. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea, febrile bone marrow aplasia, febrile neutropenia, haemoglobin decreased, hypocalcaemia, hypomagnesaemia, hyponatraemia, mucosal inflammation. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with BLEOMYCIN, CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, PREDNISONE, GRANOCYTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4568367-1
Velcade side effect was reported by a Physician from on Jan 18, 2005. Male patient, 66 years of age, weighting 172.0 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anisochromia, anisocytosis, arterial stenosis, blood chloride decreased, blood creatinine increased, blood sodium decreased, blood urea increased, c-reactive protein increased. Velcade dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5206645-3
Velcade side effect was reported by a Physician from BELGIUM on Dec 29, 2006. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, pulmonary embolism . Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5218637-9
Velcade side effect was reported by a Physician from BELGIUM on Jan 12, 2007. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, chronic obstructive pulmonary disease, conjunctivitis, constipation , fibrin d dimer increased, pulmonary embolism , pyrexia. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with ALIMTA, DAFALGAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5354877-6
Velcade side effect was reported by a Physician from UNITED STATES on May 31, 2007. Male patient, 71 years of age, weighting 183.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , blood creatinine increased, cellulitis , febrile neutropenia, groin abscess, groin pain, thrombocytopenia. Velcade dosage: 1.50 MG/M2, INTRAVENOUS. During the same period patient was treated with TYLENOL, CARVEDILOL, VICODIN, COLACE, DOXAZOSIN, ESOMEPRAZOLE, NITROGLYCERIN, HYDROXIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6025934-6
Velcade side effect was reported by a Physician from UNITED STATES on Dec 17, 2008. Male patient, 85 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration. Velcade dosage: unknown. During the same period patient was treated with ALKERAN, PREDNISONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6067854-7
Velcade side effect was reported by a Physician from UNITED STATES on Jan 21, 2009. Male patient, 85 years of age, weighting 196.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, barrett's oesophagus, blood creatinine increased, body temperature increased, dehydration, dyspnoea, pleural effusion, thrombocytopenia. Velcade dosage: 2.5 MG/M2, INTRAVENOUS. During the same period patient was treated with ALKERAN, PREDNISONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4976249-6
Velcade side effect was reported by a Physician from AUSTRIA on Apr 05, 2006. Male patient, 81 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, febrile neutropenia, haemoglobin decreased, mucosal inflammation, platelet count decreased, protein total increased, red blood cell count decreased, white blood cell count decreased. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DOXORUBICIN. Patient died on 03/31/2006.


Velcade Side Effects Report #5707892-4
Velcade side effect was reported by a Physician from JAPAN on Apr 03, 2008. Female patient, 80 years of age, weighting 74.96 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood pressure decreased, blood uric acid increased, c-reactive protein increased, cardiac failure, condition aggravated, constipation , depressed level of consciousness. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FOSAMAX, ALDACTONE, DIFLUCAN, TENORMIN, ASPIRIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PROTECADIN. Patient died on 10/24/2007.

Velcade Side Effects Report #5859616-8
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 14, 2008. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacteria urine identified, blood creatinine increased, blood pressure decreased, blood urea increased, cerebral haemorrhage, diarrhoea, haematocrit decreased, haematuria. Velcade dosage: 1.3 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with TANESPIMYCIN, FLOMAX, ASPIRIN, FAMOTIDINE, PROCHLORPERAZINE MALEATE, LORAZEPAM, ONDANSETRON, METOCLOPRAMIDE. Patient was hospitalized. Patient died on 07/30/2008.

Velcade Side Effects Report #5887989-9
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2008. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacteria urine identified, blood calcium decreased, blood creatinine increased, blood glucose increased, blood sodium decreased, blood urea increased, cerebral haemorrhage, diarrhoea, electrocardiogram abnormal. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with TANESPIMYCIN, FLOMAX, ASPIRIN, FAMOTIDINE, PROCHLORPERZINE, LORAZEPAM, ONDANESTRON, METOCLOPRAMIDE. Patient was hospitalized. Patient died on 07/30/2008.

Velcade Side Effects Report #4693867-3
Velcade side effect was reported by a Physician from on May 31, 2005. Male patient, 79 years of age, weighting 211.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, constipation , decreased appetite, diarrhoea, influenza like illness, malaise, nausea , pancytopenia, productive cough. Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with AMOXICILLIN, ATENOLOL, POTASSIUM, GLIPIZIDE, SIMVASTATIN, ANTIEMETICS AND ANTINAUSEANTS, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4694866-8
Velcade side effect was reported by a Physician from on June 07, 2005. Male patient, 79 years of age, weighting 211.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: autonomic neuropathy, blood creatinine increased, blood culture positive, constipation , decreased activity, decreased appetite, diarrhoea, immunodeficiency, influenza like illness. Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with AMOXICILLIN, ATENOLOL, POTASSIUM, GLIPIZIDE, SIMVASTATIN, ANTIEMETICS AND ANTINAUSEANTS, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5597975-4
Velcade side effect was reported by a Physician from JAPAN on Jan 07, 2008. Male patient, 78 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea, oedema, platelet count decreased, pneumonia aspiration, pyrexia, rales, vomiting, white blood cell count decreased. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with GLYBURIDE, MARZULENE, METHYCOBAL, FAMOTIDINE, MAGNESIUM OXIDE, KINEDAK, PERINDOPRIL ERBUMINE, BASEN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5608234-5
Velcade side effect was reported by a Physician from PHILIPPINES on Jan 14, 2008. Female patient, 78 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, dizziness , hypercalcaemia, urinary tract infection , vomiting. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4616532-7
Velcade side effect was reported by a Health Professional from on Feb 02, 2005. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with ZOMETA. Patient recovered.

Velcade Side Effects Report #5587235-X
Velcade side effect was reported by a Physician from JAPAN on Dec 25, 2007. Male patient, 77 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, disease progression, dyspnoea, metabolic acidosis, oedema, tumour lysis syndrome. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, SELBEX, BAKTAR, ALLOPURINOL, METHYCOBAL. Patient died on 08/03/2007.

Velcade Side Effects Report #5615699-1
Velcade side effect was reported by a Physician from JAPAN on Jan 22, 2008. Male patient, 77 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea abnormal, disease progression, dyspnoea, metabolic acidosis, oedema, tumour lysis syndrome, weight increased. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, SELBEX, BAKTAR, ALLOPURINOL, METHYCOBAL. Patient died on 08/03/2007.


Velcade Side Effects Report #4690984-9
Velcade side effect was reported by a Physician from on May 27, 2005. Male patient, 77 years of age, weighting 163.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , activated partial thromboplastin time prolonged, blood alkaline phosphatase decreased, blood bicarbonate decreased, blood bilirubin increased, blood calcium decreased, blood creatinine increased, blood glucose decreased, blood urea increased. Velcade dosage: 2.40 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, NEORECORMON, AMLODIPINE BESYLATE, OMEPRAZOLE, FOLIC ACID, DIFLUCAN. Patient was hospitalized. Patient died on 04/26/2005.

Velcade Side Effects Report #4708808-X
Velcade side effect was reported by a Physician from BELGIUM on June 20, 2005. Male patient, 77 years of age, weighting 163.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood alkaline phosphatase decreased, blood bicarbonate decreased, blood bilirubin decreased, blood calcium decreased, blood creatinine increased, blood glucose decreased, blood urea increased, c-reactive protein increased. Velcade dosage: 2.40 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, NEORECORMON, AMLODIPINE BESYLATE, OMEPRAZOLE, FOLIC ACID, DIFLUCAN. Patient was hospitalized. Patient died on 04/26/2005.

Velcade Side Effects Report #4601022-8
Velcade side effect was reported by a Pharmacist from on Mar 04, 2005. Male patient, 76 years of age, weighting 163.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood potassium increased, blood urea increased, cardio-respiratory arrest, feeling abnormal, international normalised ratio increased, liver function test abnormal, necrosis. Velcade dosage: 2.5 MG IV PUSH. During the same period patient was treated with ONDANSETRON. Patient died on 02/25/2005.

Velcade Side Effects Report #4867192-1
Velcade side effect was reported by a Pharmacist from UNITED STATES on Dec 12, 2005. Male patient, 75 years of age, weighting 132.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, myeloma recurrence. Velcade dosage: 2.20 MG, IV BOLUS. During the same period patient was treated with ZOMETA, DECADRON, ZOFRAN, BISPHOSPHONATES. Patient recovered.

Velcade Side Effects Report #4614374-X
Velcade side effect was reported by a Health Professional from on Dec 28, 2004. Male patient, 74 years of age, weighting 138.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, fatigue. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with ATENOLOL, LIPITOR. Patient recovered.


Velcade Side Effects Report #4802185-1
Velcade side effect was reported by a Health Professional from UNITED STATES on Sept 27, 2005. Male patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, disease progression, hepatic neoplasm, laboratory test abnormal. Velcade dosage: 2.50 MG. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient died on 09/05/2005.

Velcade Side Effects Report #4806908-7
Velcade side effect was reported by a Physician from GERMANY on Oct 04, 2005. Male patient, 74 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood immunoglobulin g increased, blood lactate dehydrogenase increased, c-reactive protein increased, clostridium colitis, epididymitis, gamma-glutamyltransferase increased, haemoglobin decreased. Velcade dosage: 1.80 MG, IV BOLUS. During the same period patient was treated with DEXAMETHASONE, DURAGESIC, RED BLOOD CELLS, CEFIXIME, PREDNIHEXAL, PANTOPRAZOLE, NEURONTIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6094783-5
Velcade side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Male patient, 73 years of age, weighting 231.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activities of daily living impaired, blood creatinine increased, blood urea increased, bronchitis , cellulitis , chronic obstructive pulmonary disease, coagulopathy, condition aggravated, cough. Velcade dosage: 2.77 MG, IV BOLUS. During the same period patient was treated with DEXAMETHASONE, POTASSIUM CHLORIDE, COUMADIN, FUROSEMIDE, ALLOPURINOL, HYDROCHLOROTHIAZIDE, GLUCOPHAGE, COREG. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4769118-8
Velcade side effect was reported by a Physician from UNITED STATES on May 24, 2005. Female patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, disease progression, laboratory test abnormal, renal impairment. Velcade dosage: 2.50 MG. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4558511-4
Velcade side effect was reported by a Physician from on Jan 09, 2005. Male patient, 72 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, activated partial thromboplastin time abnormal, blood calcium decreased, blood creatine phosphokinase abnormal, blood creatine phosphokinase mb abnormal, blood creatinine increased, blood sodium decreased, blood urea increased, blood uric acid abnormal. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with CARAFATE, METOPROLOL TARTRATE, FOLIC ACID, ALDACTONE, PROCRIT, LOPRESSOR, MS CONTIN, MYLANTA. Patient was hospitalized. Patient died on 03/30/2003.


Velcade Side Effects Report #4627345-4
Velcade side effect was reported by a Physician from on Mar 21, 2005. Male patient, 72 years of age, weighting 158.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, cerebellar syndrome, coordination abnormal, disease progression, dizziness , haemoglobin decreased, hyponatraemia, orthostatic hypotension, pneumonia . Velcade dosage: 1.30 MG/M2, 2/WEEK; IV BOLUS. During the same period patient was treated with TAZOCIN, LANSOPRAZOLE, ADCAL, CLODRONATE DI, METFORMIN. Patient was hospitalized and became disabled. Patient died on 10/05/2004.

Velcade Side Effects Report #4732731-8
Velcade side effect was reported by a Physician from UNITED STATES on July 11, 2005. Male patient, 72 years of age, weighting 205.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, activated partial thromboplastin time abnormal, activities of daily living impaired, blood calcium decreased, blood creatine phosphokinase abnormal, blood creatine phosphokinase mb abnormal, blood creatinine increased, blood sodium decreased, blood urea increased. Velcade dosage: 1.30 MG/M2, 2/WEEK, IV BOLUS. During the same period patient was treated with CARAFATE, METOPROLOL TARTRATE, FOLIC ACID, ALDACTONE, PROCRIT, LOPRESSOR, MS CONTIN, MYLANTA. Patient was hospitalized. Patient died on 03/30/2003.

Velcade Side Effects Report #4804363-4
Velcade side effect was reported by a Physician from UNITED STATES on Sept 29, 2005. Male patient, 72 years of age, weighting 252.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: ankle fracture, asthenia, autonomic neuropathy, blood creatinine increased, blood urea increased, fall , hypotension, joint sprain, mitral valve incompetence. Velcade dosage: 4.00 MG, INTRAVENOUS. During the same period patient was treated with GANTOVAN, ACTOS, LOTREL, CRESTOR, COMPAZINE, LORTAB, INSULIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5451071-5
Velcade side effect was reported by a Physician from JAPAN on Aug 30, 2007. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased, cardiac failure, hypotension, pleural effusion. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, OMEPRAZOLE, ALLOPURINOL, SELBEX, ZOLPIDEM TARTRATE, VERAPAMIL HYDROCHLORIDE, TAMBOCOR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6049538-4
Velcade side effect was reported by a Physician from JAPAN on Jan 09, 2009. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arteriosclerosis coronary artery, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, bronchopneumonia, disseminated intravascular coagulation, fungal infection , goitre. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, OMEPRAZOLE, ALLOPURINOL, SELBEX, ZOLPIDEM TARTRATE, VERAPAMIL HYDROCHLORIDE, TAMBOCOR, THALIDOMIDE. Patient was hospitalized. Patient died on 01/31/2008.


Velcade Side Effects Report #6053881-2
Velcade side effect was reported by a Physician from JAPAN on Jan 15, 2009. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arteriosclerosis coronary artery, blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, bronchopneumonia, condition aggravated, disseminated intravascular coagulation. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, OMEPRAZON, ALLOPURINOL, SELBEX, ZOLPIDEM TARTRATE, VERAPAMIL HYDROCHLORIDE, TAMBOCOR, THALIDOMIDE. Patient was hospitalized. Patient died.

Velcade Side Effects Report #4692464-3
Velcade side effect was reported by a Physician from on Apr 21, 2005. Male patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, blood creatinine increased, body temperature increased, dehydration, fatigue, feeling abnormal, nausea , renal failure acute. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4763452-3
Velcade side effect was reported by a Pharmacist from UNITED STATES on Aug 18, 2005. Female patient, 71 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , activated partial thromboplastin time prolonged, anorexia, blood bicarbonate decreased, blood chloride increased, blood creatinine increased, blood potassium decreased, catheter related complication, chills. Velcade dosage: 2.1 MG IV BOLUS. During the same period patient was treated with AREDIA, ARANESP, VALTREX, PREVACID, COUMADIN, BUMEX, DILAUDID, RESTORIL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5678129-X
Velcade side effect was reported by a Health Professional from SWEDEN on Mar 10, 2008. Male patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, dyspnoea. Velcade dosage: 2.70 MG, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, COCILLANA, PREDNISOLONE, KODEIN RECIP, EUSAPRIMTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4727380-1
Velcade side effect was reported by a Physician from UNITED STATES on July 11, 2005. Male patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia , asthenia, blood creatinine increased, blood potassium increased, blood urea increased, cardiac disorder, dizziness , fatigue, hypotension. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON, CORDARONE, LISINOPRIL, REGLAN, PHOSLO, ZANTAC, TOPROL, TYLENOL. Patient was hospitalized. Patient died on 03/09/2005.


Velcade Side Effects Report #4767085-4
Velcade side effect was reported by a Physician from AUSTRALIA on Aug 24, 2005. Female patient, 70 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, blood alkaline phosphatase increased, blood bicarbonate decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased, blood urea increased, blood uric acid increased. Velcade dosage: 20.00 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DOXIL, ENOXAPARIN, OXYGEN, ALBUTEROL, ANTICOAGULANT CITRATE, ANALGESICS, ANTIBIOTICS. Patient was hospitalized. Patient died on 07/24/2005.

Velcade Side Effects Report #4639392-7
Velcade side effect was reported by a Physician from on Jan 26, 2004. Male patient, 69 years of age, weighting 257.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood pressure immeasurable, breath sounds decreased, bundle branch block left, cerebrovascular accident, deep vein thrombosis , dizziness , haematocrit decreased, haemoglobin decreased. Velcade dosage: unknown. During the same period patient was treated with DECADRON, HEPARIN, ALLOPURINOL, VASOTEC, LASIX, PREVACID, WARFARIN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4690068-X
Velcade side effect was reported by a Physician from on May 31, 2005. Female patient, 68 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium decreased, blood creatine phosphokinase increased, blood creatinine increased, blood glucose increased, blood lactate dehydrogenase increased, blood sodium decreased. Velcade dosage: 1.94 MG, 2/WEEK, IV BOLUS. During the same period patient was treated with BONALON, GASTER OD, MUCOSTA, ALFAROL, LOXONIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5123305-8
Velcade side effect was reported by a Physician from JAPAN on Sept 21, 2006. Female patient, 67 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood calcium decreased, blood creatinine increased, blood lactate dehydrogenase increased, depressed level of consciousness, hepatic failure, incoherent, interleukin level increased, metastases to liver. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient died on 09/01/2005.

Velcade Side Effects Report #5139676-2
Velcade side effect was reported by a Physician from JAPAN on Oct 11, 2006. Female patient, 67 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood calcium decreased, blood creatinine increased, blood lactate dehydrogenase increased, depressed level of consciousness, incoherent, interleukin level increased, metastases to liver, oesophageal cancer metastatic. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient died on 09/01/2005.

Velcade Side Effects Report #5148540-4
Velcade side effect was reported by a Physician from JAPAN on Oct 25, 2006. Female patient, 67 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abnormal behaviour, blood calcium decreased, blood creatinine increased, creatinine renal clearance decreased, depressed level of consciousness, haemoglobin decreased, hepatic failure, incoherent, interleukin level increased. Velcade dosage: 1.30 + 1.50 MG/M2, UNK, INTRAVENOUS - SEE IMAGE. During the same period patient was treated with DEXAMETHASONE. Patient died on 09/01/2005.

Velcade Side Effects Report #5578223-8
Velcade side effect was reported by a Physician from JAPAN on Dec 10, 2007. Male patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, condition aggravated, disease progression, hypotension, nausea . Velcade dosage: 2.20 MG. During the same period patient was treated with ULCERLMIN, DEXAMETHASONE, DIGOXIN, VOLTAREN, MAGNESIUM OXIDE, CYTOTEC, PURSENNID, LANSOPRAZOLE. Patient was hospitalized. Patient died on 06/11/2007.

Velcade Side Effects Report #4610309-4
Velcade side effect was reported by a Health Professional from on Feb 16, 2005. Female patient, 66 years of age, weighting 218.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, azotaemia, beta 2 microglobulin increased, blood bilirubin increased, blood creatinine increased, blood glucose increased, blood potassium increased, haematocrit decreased, impaired healing. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, AREDIA. Patient recovered.

Velcade Side Effects Report #5030929-5
Velcade side effect was reported by a Physician from CANADA on June 06, 2006. Male patient, 66 years of age, weighting 172.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: agitation, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood calcium decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood pressure systolic increased. Velcade dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with ATORVASTATIN CALCIUM, VITAMIN E, ZOPICLONE, ACETAMINOPHEN, MEPERIDINE, IMIPENEM, CEFOTAXIME, COLACE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5122648-1
Velcade side effect was reported by a Physician from BRAZIL on Sept 22, 2006. Male patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, cough, fatigue, haemoglobin decreased, haemoptysis, hypotension, malaise, muscle spasms, myocardial infarction. Velcade dosage: 1.30 MG/M2. Patient died on 09/21/2006.


Velcade Side Effects Report #4837262-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 08, 2005. Male patient, 65 years of age, weighting 188.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, disease progression, fatigue, haematuria, herpes simplex , hyperviscosity syndrome, international normalised ratio increased, leukopenia. Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, DOXIL, COUMADIN, PEPCID, HYDROCHLOROTHIAZIDE, VALTREX. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5843026-3
Velcade side effect was reported by a Physician from JAPAN on July 29, 2008. Female patient, 64 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood albumin decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, blood uric acid increased, cardiac failure. Velcade dosage: 2.1 MG UNK INTRAVENOUS. During the same period patient was treated with PENTAMIDINE, FRAGMIN, DEXAMETHASONE, RED BLOOD CELLS, PLATELETS, GANCICLOVIR, LASIX, SOLDACTONE. Patient died on 04/15/2007.

Velcade Side Effects Report #5958969-X
Velcade side effect was reported by a Physician from UNITED KINGDOM on Nov 03, 2008. Female patient, 64 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood phosphorus increased, blood urea increased, circulatory collapse, dehydration, dizziness postural, dyspepsia, malaise, motion sickness . Velcade dosage: 2.7 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DOXORUBICIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5964957-X
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 11, 2008. Male patient, 64 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bite, blood creatinine increased, disease progression, injury, platelet count decreased, wound haemorrhage. Velcade dosage: 2.5 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #6029110-2
Velcade side effect was reported by a Physician from JAPAN on Dec 25, 2008. Female patient, 64 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma , hepatitis c  and was treated with Velcade. After drug was administered, patient experienced the following side effects: adenoviral haemorrhagic cystitis, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, cardiac failure. Velcade dosage: 2.1 MG, INTRAVENOUS. During the same period patient was treated with GANCICLOVIR, RIBAVIRIN, DEXAMETHASONE, RED BLOOD CELLS, PLATELETS, LASIX, SOLDACTONE, REMINARON. Patient died on 04/15/2007.

Velcade Side Effects Report #4865812-9
Velcade side effect was reported by a Physician from AUSTRALIA on Dec 05, 2005. Male patient, 64 years of age, weighting 153.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, duodenal ulcer haemorrhage, fall , vomiting. Velcade dosage: unknown. During the same period patient was treated with CHLORIDE, CEFROXADINE, ROXITHROMYCIN, PROCHLORPERAZINE, AGAROL, MAGMIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5753100-8
Velcade side effect was reported by a Physician from UNITED STATES on May 12, 2008. Male patient, 63 years of age, weighting 220.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood creatinine increased, blood potassium increased, blood urea increased, diarrhoea, escherichia urinary tract infection. Velcade dosage: 1.6 MG/M2, INTRAVENOUS. During the same period patient was treated with REVLIMID, VITAMIN D, DURAGESIC, VITAMIN B12, DILAUDID, ATROVENT, ALBUTEROL, PULMICORT. Patient was hospitalized. Patient died on 03/05/2008.

Velcade Side Effects Report #4716894-6
Velcade side effect was reported by a Physician from POLAND on July 01, 2005. Female patient, 63 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium increased, blood creatinine increased, blood glucose increased, blood magnesium increased, blood ph increased, cystitis, disease progression, dizziness , haemodynamic instability. Velcade dosage: 1.00 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DUROGESIC, CYCLONAMINE, MILURIT, AREDIA, FUROSEMIDE, RANIGAST. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4802909-3
Velcade side effect was reported by a Physician from GERMANY on Sept 28, 2005. Female patient, 63 years of age, weighting 178.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood creatinine increased, blood glucose increased, blood potassium increased, blood sodium decreased, dizziness , ejection fraction decreased, haematocrit decreased, haemoglobin decreased. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYCLOPHOSPHAMIDE, COTRIMTE, XANEF, CARVEDILOL, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4928093-3
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Feb 08, 2006. Male patient, 63 years of age, weighting 186.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood creatinine increased, blood phosphorus increased, blood urea increased, haemoglobin decreased, joint dislocation pathological, lymphocyte count abnormal, neutrophil count abnormal, platelet count decreased. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with PENICILLIN V, ACYCLOVIR, MORPHINE SULPHATE, QUININE SULPHATE, OMEPRAZOLE, PAMIDRONATE DI, ERYTHROPOIETIN. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5147343-4
Velcade side effect was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, atrophy, blood chloride abnormal, blood creatinine increased, c-reactive protein increased, confusional state, electroencephalogram abnormal, encephalitis . Velcade dosage: 1.30 MG/M2. During the same period patient was treated with MELPHALAN, ESCITALOPRAM, SYNTHROID, DAPSONE, PREVACID, CALCIUM, MS CONTIN, ZOMETA. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5632241-X
Velcade side effect was reported by a Physician from JAPAN on Feb 07, 2008. Male patient, 62 years of age, weighting 83.78 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, asthenia, blood creatinine increased, blood potassium increased, blood pressure increased, blood urea increased, blood uric acid increased, cardio-respiratory arrest, constipation . Velcade dosage: 1.60 MG, INTRAVENOUS,1.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MS CONTIN, FAMOTIDINE, VIT K CAP, ALOSENN, NAUZELIN, BIASAN. Patient died on 12/18/2007.

Velcade Side Effects Report #5324044-0
Velcade side effect was reported by a Physician from NETHERLANDS on Apr 26, 2007. Female patient, 61 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: affective disorder, apathy, blood creatinine increased, oral intake reduced. Velcade dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, DEXAMETHASONE, FENTANYL, MOVICOLON, ATENOLOL, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5794646-6
Velcade side effect was reported by a Physician from NETHERLANDS on June 19, 2008. Female patient, 61 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: affective disorder, apathy, blood creatinine increased, oral intake reduced. Velcade dosage: unknown. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, FENTANYL, MOVICOLON, ATENOLOL, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4765646-X
Velcade side effect was reported by a Physician from SWITZERLAND on Aug 22, 2005. Male patient, 61 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, c-reactive protein increased, dyspnoea, leukaemia plasmacytic, malignant neoplasm progression, multiple myeloma . Velcade dosage: 2.30 MG/M2, SINGLE. Patient was hospitalized. Patient died on 04/09/2005.

Velcade Side Effects Report #4943822-0
Velcade side effect was reported by a Physician from JAPAN on Feb 14, 2006. Female patient, 61 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, c-reactive protein increased, chest x-ray abnormal, disease progression, dyspnoea, haemoglobin decreased, hypoalbuminaemia, musculoskeletal chest pain, pleural effusion. Velcade dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with FAMOTIDINE, ALFAROL, SULFAMETHOXAZOLE, OZEX, DIFLUCAN, MUCODYNE. Patient died on 07/01/2005.

Velcade Side Effects Report #5128001-9
Velcade side effect was reported by a Physician from JAPAN on Sept 29, 2006. Female patient, 60 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, depressed level of consciousness, interleukin level increased, pyrexia, tumour lysis syndrome, vomiting. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #5848114-3
Velcade side effect was reported by a Physician from UNITED KINGDOM on July 29, 2008. Male patient, 60 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood phosphorus increased, blood urea increased, circulatory collapse, confusional state, decreased appetite. Velcade dosage: 2.5 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized and became disabled. Patient died on 04/26/2008.

Velcade Side Effects Report #5869584-0
Velcade side effect was reported by a Physician from UNITED KINGDOM on Aug 18, 2008. Male patient, 60 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood phosphorus increased, blood urea increased, brain scan abnormal, circulatory collapse, condition aggravated. Velcade dosage: 2.5 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized and became disabled. Patient died on 04/26/2008.

Velcade Side Effects Report #5572371-4
Velcade side effect was reported by a Physician from JAPAN on Dec 10, 2007. Male patient, 59 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma , prophylaxis and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium increased, blood creatinine increased, blood lactate dehydrogenase decreased, blood potassium decreased, blood sodium decreased, c-reactive protein increased, diarrhoea, disease progression, electrolyte imbalance. Velcade dosage: 1.70 MG, INTRAVENOUS;2.00 MG, INTRAVENOUS 1.50 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, LOPERAMIDE, AMARYL, PELTAZON, ZOLPIDEM TARTRATE. Patient died on 09/01/2007.


Velcade Side Effects Report #4596756-8
Velcade side effect was reported by a Health Professional from on Feb 15, 2005. Male patient, 59 years of age, weighting 172.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, blood creatinine increased, blood magnesium increased, blood urea increased, nausea . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4778183-3
Velcade side effect was reported by a Health Professional from UNITED STATES on Sept 06, 2005. Male patient, 59 years of age, weighting 172.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , abdominal pain upper, blood albumin decreased, blood creatinine increased, blood glucose increased, blood lactate dehydrogenase increased, blood magnesium increased, blood urea increased, cavernous sinus thrombosis. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with ACETAMINOPHEN, AEROCHAMBER INHALATION INHALER, COMBIVENT, AMMONIUM LACTATE, ARTIFICIAL TEARS SOLUTION, BISACODYL, CALCIUM CARBONATE, CAMPHOR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5214705-6
Velcade side effect was reported by a Physician from GERMANY on Jan 08, 2007. Male patient, 58 years of age, weighting 143.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONELET, GRANISETRON, RANITIDIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5249149-4
Velcade side effect was reported by a Physician from JAPAN on Feb 16, 2007. Female patient, 58 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, bronchitis , carotid bruit, dehydration, diarrhoea, disease progression, increased viscosity of bronchial secretion, injury asphyxiation. Velcade dosage: 1.30 MG/M2,. During the same period patient was treated with BAKTAR, MAGNESIUM OXIDE, FENTANYL, EBRANTIL, BESACOLIN. Patient died on 02/03/2007.

Velcade Side Effects Report #5281615-8
Velcade side effect was reported by a Physician from JAPAN on Mar 13, 2007. Female patient, 58 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood calcium decreased, blood calcium increased, blood creatinine increased, blood potassium increased, blood sodium decreased, blood uric acid increased, bronchitis . Velcade dosage: 1.30 MG/M2. During the same period patient was treated with BAKTAR, MAGNESIUM OXIDE, FENTANYL, EBRANTIL, BESACOLIN, RED BLOOD CELLS, MUCOSOLVAN, ASTOMIN. Patient died on 02/03/2007.

Velcade Side Effects Report #5299749-0
Velcade side effect was reported by a Physician from GERMANY on Mar 27, 2007. Male patient, 58 years of age, weighting 143.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, dialysis . Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONELET, GRANISETRON, RANITIDIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5076292-5
Velcade side effect was reported by a Physician from NETHERLANDS on July 26, 2006. Female patient, 58 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5488834-6
Velcade side effect was reported by a Physician from JAPAN on Oct 11, 2007. Male patient, 58 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood pressure decreased, blood urea increased, cardiac arrest , tumour lysis syndrome. Velcade dosage: 1.80 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5803594-4
Velcade side effect was reported by a Physician from JAPAN on June 25, 2008. Male patient, 58 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, dialysis , disease progression, disseminated intravascular coagulation, haemoglobin decreased. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DIFLUCAN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MUCOSTA, MAGNESIUM OXIDE, ZOLPIDEM TARTRATE, BONALON, CIPROFLOXACIN. Patient died on 12/12/2007.

Velcade Side Effects Report #4833442-0
Velcade side effect was reported by a Physician from AUSTRALIA on Nov 05, 2005. Male patient, 58 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute febrile neutrophilic dermatosis, blood creatinine increased, hypokalaemia, leukopenia, neutropenia, oral candidiasis, pneumocystis jiroveci pneumonia. Velcade dosage: 2.80 MG, QD, INTRAVENOUS. During the same period patient was treated with DOXIL, PAMIDRONATE DI, TRANSFER FACTOR, FAMCICLOVIR, MYLANTA, PARACETAMOL, PREDNISONE, PROCHLORPERAZINE. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #4865879-8
Velcade side effect was reported by a Physician from AUSTRALIA on Dec 02, 2005. Male patient, 58 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute febrile neutrophilic dermatosis, blood creatinine increased, hypokalaemia, leukopenia, neutropenia, oral candidiasis, pneumocystis jiroveci pneumonia. Velcade dosage: 2.80 MG, QD, INTRAVENOUS. During the same period patient was treated with DOXIL, PAMIDRONATE DI, TRAMSFER FACTOR, FAMCICLOVIR, MYLANTA, PARACETAMOL, PREDNISOLONE, PROCHLORPERAZINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5455169-7
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Sept 04, 2007. Male patient, 57 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, dialysis , hyperkalaemia. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #5472758-4
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Sept 17, 2007. Male patient, 57 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, dialysis , hyperkalaemia. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #5677802-7
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Mar 05, 2008. Male patient, 57 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, dialysis , hyperkalaemia. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #4990881-5
Velcade side effect was reported by a Health Professional from UNITED STATES on Jan 02, 2006. Male patient, 57 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, disease progression, musculoskeletal chest pain, neuropathy peripheral, neutropenia, rib fracture, spinal disorder. Velcade dosage: unknown. During the same period patient was treated with THALOMID, DOXIL, CORTICOSTEROIDS. Patient recovered.

Velcade Side Effects Report #5505988-3
Velcade side effect was reported by a Physician from RUSSIAN FEDERATION on Oct 22, 2007. Male patient, 56 years of age, weighting 163.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, polyneuropathy, protein total increased. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ZOMETA, CALCIUM W. Patient was hospitalized. Patient died on 06/26/2007.

Velcade Side Effects Report #4690983-7
Velcade side effect was reported by a Physician from on May 27, 2005. Male patient, 56 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , activated partial thromboplastin time shortened, blood amylase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, blood uric acid abnormal, c-reactive protein increased. Velcade dosage: 2.90 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FOLIC ACID, OMEPRAZOLE, ZOMETA. Patient was hospitalized. Patient died on 05/19/2005.

Velcade Side Effects Report #4708810-8
Velcade side effect was reported by a Physician from BELGIUM on June 20, 2005. Male patient, 56 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , activated partial thromboplastin time shortened, blood amylase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, blood uric acid decreased, escherichia sepsis. Velcade dosage: 2.90 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FOLIC ACID, OMEPRAZOLE, ZOMETA. Patient was hospitalized. Patient died on 05/19/2005.

Velcade Side Effects Report #5692776-0
Velcade side effect was reported by a Physician from JAPAN on Mar 21, 2008. Female patient, 55 years of age, weighting 90.39 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood amylase increased, blood creatinine increased, blood urea increased, bronchopulmonary aspergillosis, eosinophilia, hyperuricaemia, hypoaesthesia, hypochloraemia. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FUROSEMIDE, ALLOPURINOL, FAMOTIDINE, VORICONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FUNGUARD, BICARBONATE. Patient was hospitalized. Patient died on 12/17/2007.

Velcade Side Effects Report #5767322-3
Velcade side effect was reported by a Physician from JAPAN on May 26, 2008. Male patient, 55 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, blood calcium increased, blood creatinine increased, blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, disease progression, herpes zoster. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, GATER OD, KALIMATE, ALLOPURINOL, FIOFEMRIN R, ROHYPNOL, ZOLPIDEM TARTRATE. Patient died on 03/24/2007.

Velcade Side Effects Report #5818294-4
Velcade side effect was reported by a Physician from JAPAN on July 08, 2008. Male patient, 55 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, blood calcium increased, blood creatinine increased, blood lactate dehydrogenase increased, diarrhoea, disease progression, erythroblast count increased, herpes zoster. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FAMOTIDINE, KALIMATE, ALLOPURINOL, BIOFERMIN R, ROHYPNOL, ZOLPIDEM TARTRATE. Patient died on 03/24/2007.

Velcade Side Effects Report #5801966-5
Velcade side effect was reported by a Health Professional from FRANCE on June 23, 2008. Male patient, 54 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea haemorrhagic, grand mal convulsion, haemodialysis, haemolytic anaemia, neuropathy peripheral, paraplegia. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4847340-X
Velcade side effect was reported by a Physician from JAPAN on Nov 17, 2005. Female patient, 53 years of age, weighting 95.24 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, acute respiratory failure, atrial flutter, blood creatinine increased, blood gases abnormal, blood lactate dehydrogenase increased, blood urea increased, bone lesion, bundle branch block right. Velcade dosage: 1.70 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE, FAMOTIDINE, ALLOPURINOL, BICARBONATE, LASIX, ALENDRONATE, AREDIA. Patient died on 04/21/2004.

Velcade Side Effects Report #4610445-2
Velcade side effect was reported by a Physician from on Mar 01, 2005. Male patient, 52 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ammonia increased, anaemia, blood creatinine increased, diarrhoea, hepatic cyst, malignant neoplasm progression, mental status changes, multiple myeloma . Velcade dosage: 2.43 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with MORPHINE SULPHATE, DIAZEPAM. Patient was hospitalized. Patient died on 12/05/2004.

Velcade Side Effects Report #5725767-1
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2008. Male patient, 51 years of age, weighting 233.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute myocardial infarction, acute respiratory distress syndrome, blood creatinine increased, haemoglobin decreased, multi-organ failure, neutrophil count decreased, platelet count decreased, pleural effusion, pneumonia . Velcade dosage: 1.6 MG/M2, INTRAVENOUS. During the same period patient was treated with NEURONTIN, METOPROLOL TARTRATE, OXYCODONE, AMOXICILLIN, VALTREX, ADVAIR DISKUS. Patient died on 04/11/2008.

Velcade Side Effects Report #6104727-5
Velcade side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Female patient, 51 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: back pain , blood creatinine increased, dyspnoea exertional, hyperuricaemia, mediastinal shift, pericardial effusion, pleural effusion, renal failure acute, road traffic accident. Velcade dosage: 2.4 MG. During the same period patient was treated with OXYCODONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4613552-3
Velcade side effect was reported by a Physician from on Mar 04, 2005. Female patient, 51 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arthralgia, blood calcium decreased, blood creatinine increased, blood pressure systolic increased, diarrhoea, hypotension, lethargy, lower respiratory tract infection, oedema peripheral. Velcade dosage: 2.00 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4769812-9
Velcade side effect was reported by a Health Professional from UNITED STATES on June 20, 2005. Male patient, 50 years of age, weighting 171.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium increased, blood creatinine increased, confusional state, disease progression, pyrexia. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. Patient was hospitalized. Patient died on 05/30/2005.

Velcade Side Effects Report #4805557-4
Velcade side effect was reported by a Health Professional from UNITED STATES on Oct 03, 2005. Male patient, 50 years of age, weighting 171.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anxiety , asthenia, blood creatinine increased, confusional state, cough, disease progression, dizziness , gait disturbance. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with ZOLOFT, FENTANYL, OXYCONTIN, VICODIN. Patient was hospitalized. Patient died on 05/30/2005.

Velcade Side Effects Report #4903594-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2006. Male patient, 50 years of age, weighting 171.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, asthenia, blood calcium increased, blood creatinine increased, confusional state, cough, disease progression, dizziness , gait disturbance. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with ZOLOFT, FENTANYL, OXYCONTIN, VICODIN. Patient was hospitalized. Patient died on 05/30/2005.

Velcade Side Effects Report #4940826-9
Velcade side effect was reported by a Health Professional from UNITED STATES on Feb 21, 2006. Male patient, 50 years of age, weighting 171.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anxiety , asthenia, blood creatinine increased, confusional state, cough, depression , disease progression, dizziness . Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with ZOLOFT, FENTANYL, OXYCONTIN, VICODIN. Patient was hospitalized. Patient died on 05/30/2005.